FDA Warning Letter: ImprimisRx NJ
type: Action
additional type: https://schema.org/RegulationAction
start time: 2023-06-06
description: Compounding Pharmacy/Adulterated Drug Products. Issued by FDA Division of Pharmaceutical Quality Operations I on 2023-05-26.
agent: FDA Division of Pharmaceutical Quality Operations I
object: ImprimisRx NJ
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters
source organization: U.S. Food and Drug Administration
publisher: AI Analytics

PropertyValue
property ID: FDA Warning Letter ID
value: 28bbc7a3243e7947

AI Analytics
type: Organization